Rain Therapeutics Inc. (RAIN) Social Stream



Rain Therapeutics Inc. (RAIN): $0.85

0.00 (-0.52%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add RAIN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#317 of 359

in industry

RAIN ONCOLOGY INC (RAIN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RAIN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-10 3 $28 $25 $26.333 $0.822 3103.53%
2022-03-03 3 $28 $26 $26.666 $0.822 3144.04%
2022-05-04 4 $28 $15 $23.75 $0.822 2789.29%
2022-05-05 4 $28 $16 $24 $0.822 2819.71%
2022-05-27 2 $16 $12 $14 $0.822 1603.16%
2022-08-05 3 $16 $12 $14.666 $0.822 1684.18%
2022-11-11 4 $16 $10 $13.5 $0.822 1542.34%
2022-11-23 5 $29 $12 $17 $0.822 1968.13%
2023-01-05 7 $29 $12 $16.833 $0.822 1947.81%
2023-01-06 6 $29 $12 $17 $0.822 1968.13%
2023-01-20 6 $29 $12 $17.5 $0.822 2028.95%
2023-01-23 7 $29 $12 $17.5 $0.822 2028.95%
2023-03-10 8 $29 $12 $18 $0.822 2089.78%
2023-03-13 8 $29 $15 $18.75 $0.822 2181.02%
2023-05-15 9 $24 $11 $17.333 $0.822 2008.64%
2023-05-23 9 $17 $1.5 $9.156 $0.822 1013.87%
2023-05-30 10 $17 $1.5 $6.607 $0.822 703.77%
2023-05-31 10 $17 $1.2 $6.492 $0.822 689.78%
2023-08-10 9 $17 $1 $4.208 $0.822 411.92%

The Trend in the Analyst Price Target


RAIN's average price target has moved down $21.47 over the prior 23 months.

RAIN reports an average of 185.19% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-05 7 29 12 16.833 8.66 94.38%
2023-01-23 8 29 12 17.500 9.85 77.66%
2023-02-09 8 29 12 18.000 9.00 100%
2023-03-10 8 29 12 18.000 8.99 100.22%
2023-05-15 9 24 11 17.333 9.58 80.93%

RAIN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 9 0 0 9

The Trend in the Broker Recommendations


RAIN's average broker recommendation rating worsened by 2 over the prior 17 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, RAIN ONCOLOGY INC's upside potential (average analyst target price relative to current price) is higher than 3034.5% of them.
  • To contextualize these metrics, consider that out of all US stocks, RAIN ONCOLOGY INC's variance in analysts' estimates is lower than -2020.14% of them.
  • In the context of stocks in the small market cap category, RAIN ONCOLOGY INC's number of analysts covering the stock is higher than 2034.32% of them.
  • RAIN ONCOLOGY INC's average analyst price target is greater than 886.88% of Healthcare stocks.

Stocks similar to RAIN ONCOLOGY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HOWL, VACC, and VERA.

What is the outlook for RAIN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!